HAVCR2 and Parkinson disease: To assess the role of the Gal-9 receptor Tim-3 in the PD model, WT mice were intraperitoneally injected with Tim-3 antibody (50 μg/mice) for 7 days 2 h before MPTP injection to block Tim-3 function.